Grade-dependent Response to Finasteride in Early Prostate Cancer

Ferenc G. Rick; Norman L. Block

doi:10.1016/j.ebiom.2016.04.022

Grade-dependent Response to Finasteride in Early Prostate Cancer

Ferenc G. Rick, Norman L. Block

Urology

Research output: Contribution to journal › Comment/debate

Original language	English (US)
Pages (from-to)	13-14
Number of pages	2
Journal	EBioMedicine
Volume	7
DOIs	https://doi.org/10.1016/j.ebiom.2016.04.022
State	Published - May 1 2016

Keywords

5-alpha reductase inhibitor
Androgen-deprivation therapy
Chemoprevention
Early prostate cancer
Finasteride
Gleason grade

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1016/j.ebiom.2016.04.022

Cite this

Rick, F. G., & Block, N. L. (2016). Grade-dependent Response to Finasteride in Early Prostate Cancer. EBioMedicine, 7, 13-14. https://doi.org/10.1016/j.ebiom.2016.04.022

@article{1af4ac1ec4a24ced9e6581ee00e26bb3,

title = "Grade-dependent Response to Finasteride in Early Prostate Cancer",

keywords = "5-alpha reductase inhibitor, Androgen-deprivation therapy, Chemoprevention, Early prostate cancer, Finasteride, Gleason grade",

author = "Rick, {Ferenc G.} and Block, {Norman L.}",

year = "2016",

month = may,

day = "1",

doi = "10.1016/j.ebiom.2016.04.022",

language = "English (US)",

volume = "7",

pages = "13--14",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Grade-dependent Response to Finasteride in Early Prostate Cancer

AU - Rick, Ferenc G.

AU - Block, Norman L.

PY - 2016/5/1

Y1 - 2016/5/1

KW - 5-alpha reductase inhibitor

KW - Androgen-deprivation therapy

KW - Chemoprevention

KW - Early prostate cancer

KW - Finasteride

KW - Gleason grade

UR - http://www.scopus.com/inward/record.url?scp=84966699072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966699072&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2016.04.022

DO - 10.1016/j.ebiom.2016.04.022

M3 - Comment/debate

C2 - 27322449

AN - SCOPUS:84966699072

VL - 7

SP - 13

EP - 14

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

ER -